Sign Up to like & get
recommendations!
0
Published in 2022 at "Drug and chemical toxicology"
DOI: 10.1080/01480545.2022.2029880
Abstract: Methotrexate (MTX) has been in use for the treatment of rheumatoid arthritis (RA), psoriasis, and cancer since 1948. Its toxic side effects on tissues and organs have been well documented but splenotoxicity has not been…
read more here.
Keywords:
mtx;
ada mtx;
mtx ada;
induced toxicity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-214894
Abstract: Objective To compare the effects of interleukin-6 (IL-6) receptor and tumour necrosis factor inhibition on inducing repair of existing bone erosions in patients with very early rheumatoid arthritis (RA). Methods Prospective non-randomised observational study in…
read more here.
Keywords:
erosion;
bone;
disease activity;
ada mtx ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.1469
Abstract: Background: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Patients (pts) with RA are at increased risk for herpes zoster (HZ) and this risk is further increased with tofacitinib…
read more here.
Keywords:
ada mtx;
pfizer inc;
pts received;
pfizer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.6108
Abstract: Filgotinib (FILG) is a JAK1 inhibitor that has been investigated in combination with methotrexate (MTX) for the treatment of moderate-to-severe rheumatoid arthritis (RA). To date, no head-to-head trial has compared the efficacy of FILG versus…
read more here.
Keywords:
tofa mtx;
ada mtx;
mtx;
200 mtx ... See more keywords